Further, metformin was associated with decreased serum soluble vascular cell-adhesion molecule-1 (sVCAM-1) and soluble ICAM-1 levels in patients with type 2 diabetes during a follow up of 4 years [54]. This evidence concerns the gene ICAM1 and type 2 diabetes mellitus.